NASDAQ · LIPIX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 02:18 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BlackRock LifePath Index 2050 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BlackRock LifePath Index 2050 Fund’s forward annual dividend is $0.04 per share, paid semi-annual. The forward yield is 0.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund strategically manages its portfolio by investing in a diverse mix of other investment vehicles, specifically equity index funds, fixed-income index funds, and money market funds. The proportions of these underlying holdings are periodically adjusted in line with the fund's distinct, overarching investment strategy. Typically, a significant portion—at least 80%—of its total assets will be channeled into securities or other financial instruments that either directly comprise or exhibit comparable economic attributes to those found within its bespoke benchmark, the LifePath Index 2050 Fund Custom Benchmark.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$50.21+$0.76 (+1.54%)
Victory Sycamore Established Value Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
$46.69-$0.02 (-0.04%)
FPA Crescent Fund’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
$27.44-$0.09 (-0.33%)
MFS Research International R2’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
$22.95$0.00 (0.0%)
BlackRock LifePath Index 2035 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.84% below the high.
$25.55-$0.02 (-0.08%)
T. Rowe Price Retirement 2055 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.59% below the high.
$36.29+$0.56 (+1.57%)
MFS Mid Cap Value Fund’s quoted price sits in the upper half of its reported 52-week range, 2.5% below the high.
$28.54$0.00 (0.0%)
BlackRock LifePath Index 2045 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.26% below the high.
$60.51+$0.01 (+0.02%)
Hartford Core Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 1.63% below the high.
